Axsome Therapeutics, INC. (AXSM) SEC Filings — 2025

Filings

• Axsome Therapeutics Files 8-K — 8-K · Dec 31, 2025
• Axsome's Revenue Soars 66% on New Drug Launch, Losses Narrow — 10-Q · Nov 3, 2025
• Axsome Therapeutics Files 8-K — 8-K · Aug 20, 2025
• Axsome's Revenue Soars 75% on Auvelity, Sunosi Sales; Net Loss Narrows — 10-Q · Aug 4, 2025
• Axsome Therapeutics Files 8-K — 8-K · Jun 10, 2025
• Axsome Therapeutics Files 8-K — 8-K · Jun 9, 2025
• Axsome Therapeutics Files 8-K — 8-K · May 27, 2025
• Axsome Therapeutics Files 8-K with Key Agreements and Sales — 8-K · May 13, 2025
• Axsome Therapeutics Files Q1 2025 10-Q — 10-Q · May 5, 2025
• Axsome Therapeutics DEF 14A: Executive Compensation Details — DEF 14A · Apr 25, 2025
• Axsome Therapeutics Files 8-K — 8-K · Apr 1, 2025
• Axsome Therapeutics Files 8-K Report — 8-K · Mar 25, 2025
• Axsome Therapeutics Files 8-K — 8-K · Mar 5, 2025
• Axsome Therapeutics Files 8-K — 8-K · Mar 3, 2025
• Axsome Therapeutics, INC. 10-K Filing — 10-K · Feb 18, 2025
• Axsome Therapeutics Files 8-K Report — 8-K · Feb 10, 2025
• Axsome Therapeutics Files 8-K Report — 8-K · Jan 31, 2025
• Axsome Therapeutics Files 8-K on Financials and Events — 8-K · Jan 13, 2025